Current treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany

被引:0
|
作者
Vogt, D. [1 ]
Haritoglou, C. [2 ]
Nicoletti, V. [1 ]
Kortuem, F. C. [3 ]
Deiters, V. [4 ]
Hoerauf, H. [5 ]
Wolf, A. [1 ]
Schumann, R. G. [1 ,6 ]
机构
[1] Univ Klinikum Ulm, Klin Augenheilkunde, Prittwitzstr 43, D-89075 Ulm, Germany
[2] Augenklin Herzog Carl Theodor, Munich, Germany
[3] Univ Klinikum Tubingen, Augenklinik, Tubingen, Germany
[4] Ludwig Maximilians Univ Munchen, Augenklin Univ Munchen, Munich, Germany
[5] Univ Med Gottingen, Augenklinik, Gottingen, Germany
[6] Augenzentrum & Gefassmed Munchen Schwabing, Munich, Germany
来源
OPHTHALMOLOGIE | 2024年 / 121卷 / 12期
关键词
Macular hole; Vitrectomy; Vitreolysis; Vitreomacular traction; Ocriplasmin; PARS-PLANA VITRECTOMY; PNEUMATIC VITREOLYSIS; OCRIPLASMIN;
D O I
10.1007/s00347-024-02118-1
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: To evaluate the different treatment strategies for eyes with vitreomacular traction (VMT) and macular holes (MF) regarding the indications and initiation of treatment. ObjectiveThe aim of this study is to facilitate clinical decision making by presenting the opinions of experienced retinal specialists in the context of the current literature and the changed approval situation for ocriplasmin. Material and methods: Members of the German Retina Society (RG) were questioned in an online survey. Based on a literature review a 100-question questionnaire was created and sent to all members of the RG via an electronic link to the online platform "LimeSurvey". Voluntary participation was possible from 15 October 2021 to 15 November 2021. Data collection and statistical analysis were anonymized. Results: The responses of the 115 participants were congruent with the presentation of the new S1 guidelines on this topic. The indications for active treatment of focal VMT without MF were postponed in favor of watchful waiting, with the individual symptoms of the patient playing a major role in the proposed temporal management. The results on the indications for vitrectomy are consistent and convincingly confirm the opinions on the efficacy and risk assessment of this therapeutic procedure. Conclusion: The results presented provide an overview of the consensus and controversies in the current treatment options for VMT and MF. With the help of a homogeneous and experienced group of retinal experts, it was possible to develop individual treatment strategies.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 48 条
  • [1] Update zur Behandlungsstrategie bei vitreomakulärer Traktion und Makulaforamen: eine Umfrage unter Retinologen in DeutschlandCurrent treatment strategies for vitreomacular traction and macular holes: a survey of retinal specialists in Germany
    D. Vogt
    C. Haritoglou
    V. Nicoletti
    F. C. Kortuem
    V. Deiters
    H. Hoerauf
    A. Wolf
    R. G. Schumann
    Die Ophthalmologie, 2024, 121 (12) : 973 - 984
  • [2] Initial Clinical Experience in the Treatment of Vitreomacular Traction and Macular Holes with Ocriplasmin
    Lommatzsch, A. P.
    Gutfleisch, M.
    Dietzel, M.
    Heimes, B.
    Spital, G.
    Boehme, M.
    Bornfeld, N.
    Pauleikhoff, D.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2014, 231 (09) : 909 - 914
  • [3] Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment
    Steel, D. H. W.
    Lotery, A. J.
    EYE, 2013, 27 : S1 - S21
  • [4] ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES Results of OVIID-1 Trial
    Tadayoni, Ramin
    Holz, Frank G.
    Zech, Christophe
    Liu, Xin
    Spera, Claudio
    Stalmans, Peter
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (12): : 2341 - 2352
  • [5] Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
    Jackson, Timothy L.
    Verstraeten, Thomas
    Duchateau, Luc
    Lescrauwaet, Benedicte
    ACTA OPHTHALMOLOGICA, 2017, 95 (08) : e740 - e745
  • [6] Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes
    Baumann, Carmen
    Sabatino, Francesco
    Zheng, Yalin
    Johannigmann-Malek, Navid
    Maier, Mathias
    Kaye, Stephen B.
    Patton, Niall
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) : 2209 - 2215
  • [7] Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes
    Carmen Baumann
    Francesco Sabatino
    Yalin Zheng
    Navid Johannigmann-Malek
    Mathias Maier
    Stephen B. Kaye
    Niall Patton
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2209 - 2215
  • [8] Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment
    D H W Steel
    A J Lotery
    Eye, 2013, 27 : S1 - S21
  • [9] Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy
    Maier, M.
    Abraham, S.
    Frank, C.
    Lohmann, C. P.
    Feucht, N.
    OPHTHALMOLOGE, 2017, 114 (02): : 148 - 154
  • [10] Pneumatic vitreolysis versus vitrectomy for the treatment of vitreomacular traction syndrome and macular holes: complication analysis and systematic review with meta-analysis of functional outcomes
    Miguel A. Quiroz-Reyes
    Erick A. Quiroz-Gonzalez
    Miguel A. Quiroz-Gonzalez
    Virgilio Lima-Gomez
    International Journal of Retina and Vitreous, 9